Here is What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX)
“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively...
Posts Tagged ‘NASDAQ:PGNX’
Progenics Pharmaceuticals, Inc. (PGNX) Is Burning These Hedge Funds
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Here’s What Hedge Funds Think About Progenics Pharmaceuticals, Inc. (PGNX)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Market Movers Today: Dropbox, Inc. (DBX), Micron Technology, Inc. (MU), New York & Company, Inc. (NWY), Geron Corporation (GERN), and More
Dropbox, Inc. (NASDAQ:DBX) (Reuters) (Reuters) – Dropbox Inc’s shares soared by as much as 50 percent in their first day of trading on Friday...
Is Progenics Pharmaceuticals, Inc. (PGNX) a Good Stock to Buy?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of...
Portfolio Cuts Couldn’t Stop HealthInvest From Buying Up These Stocks
HealthInvest Partners AB is a Stockholm-based fund management company co-founded by Carl Bennet and Anders Hallberg in 2006, which specializes in the...
Biotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant Pharmaceuticals Intl Inc (VRX) Progenics Pharmaceuticals, Inc. (PGNX)
Last week, the FDA had two major decisions to make regarding troubled drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The first was whether or...
Why Valeant, Progenics, Ryerson, Zafgen and TerraForm Are On The Move Today
U.S stocks headed back into the green on Wednesday, helped by strong earnings reports from the tech sector and a rebound in oil prices, driven by a slightly...
Here’s Why These Five Stocks Are Trending
It’s been a quiet day on Wall Street so far, as the three major index futures haven’t deviated much from yesterday’s close. However,...
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross...
Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains
Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX)....
Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX)
Kevin Kotler is bullish on Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) and has decided to boost his fund’s investment in the stock. Kotler’...
Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It
Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a good investment? To the average investor, there are tons of indicators shareholders can use to watch...
Here is What Hedge Funds Think About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)
Is it smart to be bullish on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? At the moment, there are tons of metrics shareholders can use to monitor their...
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
Is it smart to be bullish on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? At the moment, there are tons of methods market participants can use to watch...
Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week
With August winding down, summer won’t be around much longer. Several health-care stocks still had hot days this past week, though. Here are three...
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view. The number of bullish hedge fund...
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds’ portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest...
Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?
Cerus Corporation (NASDAQ:CERS) has experienced an increase in hedge fund sentiment in recent months. In today’s marketplace, there are a multitude...
Should You Buy XOMA Corp (XOMA)?
XOMA Corp (NASDAQ:XOMA) investors should be aware of an increase in hedge fund interest recently. In the eyes of most stock holders, hedge funds are seen...
Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?
Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a worthy investment now? Prominent investors are taking an optimistic view. The number of bullish hedge...
Hedge Funds Are Betting On Cerus Corporation (CERS)
Is Cerus Corporation (NASDAQ:CERS) a buy, sell, or hold? Prominent investors are turning bullish. The number of long hedge fund positions advanced by...
This Metric Says You Are Smart to Buy Progenics Pharmaceuticals, Inc. (PGNX) – Cerus Corporation (CERS), XOMA Corp (XOMA)
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) investors should pay attention to an increase in support from the world’s most elite money managers...
